AKEBIA THERAPEUTICS, INC. Convertible Preferred Stock, Shares Issued upon Conversion
AKEBIA THERAPEUTICS, INC. (AKBA) had Convertible Preferred Stock, Shares Issued upon Conversion of 0 shares as of 2014-12-31, per its 10-K filed 2018-03-12.
Discontinued › Notes › Stockholders' Equity Note › Class of Stock Disclosures
us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion · last filed 2018-03-12
- 2014-12-31: Convertible Preferred Stock, Shares Issued upon Conversion 0.00 shares.
- 2014-09-30: Convertible Preferred Stock, Shares Issued upon Conversion 0.00 shares.
- 2014-03-31: Convertible Preferred Stock, Shares Issued upon Conversion 0.00 shares.
- 2014-03-25: Convertible Preferred Stock, Shares Issued upon Conversion 12.12M shares.
| Period end | Convertible Preferred Stock, Shares Issued upon Conversion |
|---|---|
| 2014-12-31 | 0.00 shares 10-K · filed 2018-03-12 |
| 2014-09-30 | 0.00 shares 10-Q · filed 2014-11-10 |
| 2014-03-31 | 0.00 shares 10-Q · filed 2014-08-11 |
| 2014-03-25 | 12.12M shares 10-K · filed 2018-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |